US OptionsDetailed Quotes
ADAP241115C2500
- 0.00
- 0.000.00%
15min DelayTrading Nov 6 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest2.50Strike Price0.00Turnover0.00%IV194.12%PremiumNov 15, 2024Expiry Date0.00Intrinsic Value100Multiplier9DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma1.13Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Adaptimmune Therapeutics Stock Discussion
Sign in to post a comment
$Adaptimmune Therapeutics (ADAP.US)$ .. green when is the pre-market , will drop once open market!!!
1
$Adaptimmune Therapeutics (ADAP.US)$ Item 1.01Entry into a Material Definitive Agreement.
On September 23, 2024, Adaptimmune Therapeutics plc (the “Company”) entered into a Mutual Release and Resolution Agreement (the “Agreement”) with Genentech Inc and F. Hoffmann-La Roche Ltd, (together “Genentech”). The parties entered into the Agreement following notice of termination of their Collaboration and License Agreement dated September 3, 2021 (the “Collaboration Agreement”) on April 8,...
On September 23, 2024, Adaptimmune Therapeutics plc (the “Company”) entered into a Mutual Release and Resolution Agreement (the “Agreement”) with Genentech Inc and F. Hoffmann-La Roche Ltd, (together “Genentech”). The parties entered into the Agreement following notice of termination of their Collaboration and License Agreement dated September 3, 2021 (the “Collaboration Agreement”) on April 8,...
2
2
$Adaptimmune Therapeutics (ADAP.US)$
so the spike in cash is from financing, fyi
so the spike in cash is from financing, fyi
1
20% before didn't TP. will wait patiently... or maybe CL...
after the product is approved, profitable, it's your time to shine.
$Adaptimmune Therapeutics (ADAP.US)$
after the product is approved, profitable, it's your time to shine.
$Adaptimmune Therapeutics (ADAP.US)$
3
$Adaptimmune Therapeutics (ADAP.US)$
😩. I wish I had more capital. This is about to run hard.
😩. I wish I had more capital. This is about to run hard.
1
$Adaptimmune Therapeutics (ADAP.US)$ HC Wainwright & Co. Reiterates Buy on Adaptimmune Therapeutics, Maintains $4 Price Target
No comment yet
hardeep dhaliwal : How’s that stock for long term according to you?